Company Filing History:
Years Active: 2020-2024
Title: Karthikeyan Murugesan: Innovator in Antibiotic Resistance Solutions
Introduction
Karthikeyan Murugesan is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of antibiotic resistance through his innovative patents. With a total of 2 patents, his work focuses on utilizing genomic data to enhance the understanding and prediction of antibiotic susceptibility in bacterial pathogens.
Latest Patents
Murugesan's latest patents include groundbreaking methods and systems for predicting the susceptibility of bacterial pathogens to antibiotics using genomic datasets. The first patent, titled "Analytic prediction of antibiotic susceptibility," describes a process where genomic datasets are analyzed using principal variance component analysis to determine the effect sizes of various labels. This information is then employed in a machine learning model to make predictions on future datasets.
The second patent, "Antibiotic resistance causation identification," outlines methods for identifying the genetic mechanisms that cause antibiotic resistance in pathogens. This system includes a gene resistance module to identify genes in antibiotic-resistant pathogens, a single nucleotide polymorphism module to detect mutations, and an antibiotic resistance module that outputs the causation of resistance based on the identified genes and mutations.
Career Highlights
Karthikeyan Murugesan is currently employed at Koninklijke Philips Corporation N.V., where he continues to advance his research in antibiotic resistance. His work is pivotal in addressing the growing concern of antibiotic resistance, which poses a significant threat to public health.
Collaborations
Some of his notable coworkers include Nevenka Dimitrova and Henry Lin, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Karthikeyan Murugesan's innovative work in the field of antibiotic resistance showcases his commitment to improving healthcare through technology. His patents reflect a deep understanding of genomic data and its application in combating antibiotic resistance.